ORCID: 0000-0001-6111-0754
ethz.ch/en/news-and-...
ethz.ch/en/news-and-...
The basic claim is that mRNA vaccines had huge synergistic benefit with checkpoint blockade against lung cancer melanoma.
tl;dr it's glam-slop & everyone involved should be embarrassed
The basic claim is that mRNA vaccines had huge synergistic benefit with checkpoint blockade against lung cancer melanoma.
tl;dr it's glam-slop & everyone involved should be embarrassed
We are offering a super exciting project to investigate cytoskeletal dynamics in Circulating Tumour Cells from Breast Cancer Patients.
We are offering a super exciting project to investigate cytoskeletal dynamics in Circulating Tumour Cells from Breast Cancer Patients.
👉In our interview she shares insights on #WomenInScience, #Sustainability & research challenges
Have a read!👇
https://tuit.cat/pbPgm
#PRBBcommunity
👉In our interview she shares insights on #WomenInScience, #Sustainability & research challenges
Have a read!👇
https://tuit.cat/pbPgm
#PRBBcommunity
👉 authors.elsevier.com/a/1lk-k3qNrU...
We summarized for @cp-immunity.bsky.social
"Neutrophils drive vascular occlusion, tumour necrosis and metastasis" published in @nature.com by @megeblad.bsky.social @adrover.bsky.social rdcu.be/eFdau
Congrats!
👉 authors.elsevier.com/a/1lk-k3qNrU...
We summarized for @cp-immunity.bsky.social
"Neutrophils drive vascular occlusion, tumour necrosis and metastasis" published in @nature.com by @megeblad.bsky.social @adrover.bsky.social rdcu.be/eFdau
Congrats!
📣 The #IBE_Barcelona is seeking a #PhD Student for the Evolutionary #Microbiology Lab.🔬🧫
⏳ Apply before September 30th and #JoinOurTeam!
#UnravellingEvolution #ConservingBiodiversity
✍ https://www.ibe.upf-csic.es/work-with-us/job-offers
mathematical-oncology.org/blog/machine...
@hamiscalculated.bsky.social @jmetzcar.bsky.social @stolzbernadette.bsky.social
#MathOnco #MachineLearning
mathematical-oncology.org/blog/machine...
@hamiscalculated.bsky.social @jmetzcar.bsky.social @stolzbernadette.bsky.social
#MathOnco #MachineLearning
New out in #NatureMedicine: A phase 1 trial shows that the size of #CTC clusters (which can promote metastatic spread) can be reduced by treatment with the Na+/K+ ATPase inhibitor #digoxin in patients with metastatic #BreastCancer. By Nicola Aceto et al.
www.nature.com/articles/s41...
New out in #NatureMedicine: A phase 1 trial shows that the size of #CTC clusters (which can promote metastatic spread) can be reduced by treatment with the Na+/K+ ATPase inhibitor #digoxin in patients with metastatic #BreastCancer. By Nicola Aceto et al.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
www.nature.com/articles/s41...
www.cararthompson.com/posts/2025-0...
Colour can be used to emphasise different stories - pick the approach you need!
www.cararthompson.com/posts/2025-0...
Colour can be used to emphasise different stories - pick the approach you need!
For me this was discovery science as I had always hoped it would be. A lot of fun, and some proper detective work with plenty of twists & turns on the way. Brief thread below
For me this was discovery science as I had always hoped it would be. A lot of fun, and some proper detective work with plenty of twists & turns on the way. Brief thread below
aacrjournals.org/cancerres/ar...
aacrjournals.org/cancerres/ar...